Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

Y1 TP2 Infection (topic 3 Onwards) > 4. Antibiotics And Antimicrobials > Flashcards

4. Antibiotics And Antimicrobials Flashcards

1
Q

4 antimicrobials (classification)

A
  • Antibacterial – antibiotics
    • Antifungal
    • Antiviral
    • Antiprotozoal
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

4 Classification of antibacterial agents

A

– bactericidal or bacteriostatic
– spectrum – ‘broad’ v. ‘narrow’
– target site (mechanism of action)
– chemical structure (antibacterial class)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Define – bactericidal bacteriostatic

A
  • Bacterialcidial = kill bacteria compeltely

* Bacteriostatic = stop bacteria replicating

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Define spectrums of antibiotics

A

– spectrum – ‘broad’ v. ‘narrow’
• Treat a broad spectrum of organisms e.g. treat both gram positive and negatitive
• Treat narrow range

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

6 ideal features of antimicrobial agents

A
  • Selectively toxic
  • Few adverse effects
  • Reach site of infection
  • Oral/IV formulation
      ○ Oral drugs are easier to deliver

• Long half-life (infrequent dosing)
○ How long drug lasts in body and how often to take drugs

• No interference with other drugs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Selecting the best antibiotic

A

1 empirical therapy → give best broad spectrum antibiotic as you have not yet identified causative organisms

  1. Isolate and identify causative organism
  2. Determine its sensitivity to antibiotics

4 • treat with appropriate narrow antibiotic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

4 antibacterial mechanisms of action

A

Interfere with Cell wall synthesis

Interfere with Cell membrane function

Interfere with Protein synthesis – impact bacteria that produce proteins (toxins)

Interfere with Nucleic acid synthesis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Examples of antibacterials that

Interfere with Cell wall synthesis

A

• β-lactams
- bind to enzymes that form cross links between peptidoglycan so prevent cell wall synthesis , gram positive bacteria burst due to high internal osmotic pressure

• Glycopeptides
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Examples of antibacterials that

Interfere with Cell membrane function

A
  • Polymixins (e.g. colistin)

* Daptomycin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Examples of antibacterials that

Interfere with Protein synthesis

A
  • Tetracyclines 30s
  • Aminoglycosides 30s

• Macrolides 50s

Antibiotics binds to 30s or 50s ribosomal - subunit causing interference in protein synthesis as mrna is misread or not read

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Examples of antibiotics that

Interfere with Nucleic acid synthesis

A

• Quinolones
Bind to dna and enzymes in gram negative causing breaks in dna

* Trimethoprim 
* Rifampicin

Inhibit bacterial cell dna synthesis = death as it inhibits dna gyrase and topoisomerase iv enzymes needed for replication

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

4 mechanisms of resistance (that bacteria develop)

A
  • Drug inactivating enzymes (inactivate antibioticis)
  • Altered target
  • Altered uptake
  • Biofilm mode of growth
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

3 types of mechanisms of resistance (that bacteria develop)

A

Intrinisic
Acquired
Adaptive

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Intrinsic resistance

A
  • no target or restricted access for drug

Bacteria are just naturally resistance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Acquired resistance

A

Mutates or accquires new genetic material

= most problematic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Adaptative resistance

A

Organism responds to a stress and adapts to its new growth enviroment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Examples of • Drug inactivating enzymes (inactivate antibioticis)

A
  • e.g. β-lactamases, = beta lactamase breaks up beta lactamase ring of penicillin
    • aminoglycoside enzymes
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Mechanisms of resistance

-Altered target

A

• target has lowered affinity for antibacterial e.g. resistance to methicillin, macrolides & trimethoprim

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Mechanisms of resistance

• Altered uptake

A
  • ↓permeability, so antibiotic can’t easily go into bacteria
    • or ↑efflux, to pump antibiotics out
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Mechanisms of resistance

• Biofilm mode of growth

A

• Bacteria form biofilm, big tent thing to protect them

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

4 Genetic mechanisms of resistance

A

Transformation

Transposition

Conjugation

Mutation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Transformation

Genetic mechanisms of resistance

A

• direct uptake of DNA containing resistance genes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Transposition

Genetic mechanisms of resistance

A

• movement of resistance genes from plasmids to genome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Conjugation

Genetic mechanisms of resistance

A

• plasmids containing resistance genes are transferred from other organisms

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Mutation

Genetic mechanisms of resistance

A

• base changes or deletions lead to altered targets of antibiotic action

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

3 ways of measuring antibiotic activity

A

• Disc sensitivity testing
Antibiotic sensitivity by Etest
Automated antibiotic sensitivity testing

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

• Disc sensitivity testing:

A

○ Sensitive
○ Intermediate = few bacteria grow
○ Resistant = nothing happens around zone bacteria still grow

Look at zones of inhibition to find most effective antibiotic
• Know which antibiotic is the most important

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

Antibiotic sensitivity by Etest

A

• Minimum inhibitory concetration MIC as mg/L
○ Minimum concentration of that antibiotic that inhibits bacterial growth

* Strip with different concentrations of antibiotics 
* Minimum inhibitory concentration is where zone of bacteria stops
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

Automated antibiotic sensitivity testing

A

• Much faster
• Minimum inhibitory concetration MIC as mg/L
○ Minimum concentration of that antibiotic that inhibits bacterial growth

30
Q

Considerations for antibiotic therapy

A
  • when to use antibiotic depends on Severity /cause of infection
  • Consider patient’s medical history, other drugs and allergy to antibiotics (e.g. allergy to penicillin)
  • Taking samples (eg swab, blood, urine sample, tissue or bone sample) before start of antibiotic therapy
  • Broad spectrum antibiotics should be used if there is an urgency and the causative organism has not been identified
  • Route of administration
  • Dose of antibiotics
  • Combination therapy = 2 antibiotics at a time
  • Longevity of therapy
  • Prophylaxis = problem with heart valves, heart valves can be very prone to infection
31
Q

Examples of beta lactams

More info on 4’1 slides

A
  • Penicillins
  • Cephalosporins
    • Carbapenems
  • Monobactams
32
Q

Penicillin

A

• mainly active against streptococci

33
Q

3 types of penicillins

A

Penicillin
Amoxicillin
Flucloxacillin

34
Q

Amoxicillin

A
  • also some activity against Gram-negatives

* Broad spectrum

35
Q

Flucloxacillin

A

• active against staphylococci & streptococci

36
Q

Penicillins: β-lactamase inhibitor combinations

A
  • amoxicillin/clavulanate (all of above +anaerobes + Gram negative bacteria)
    • piperacillin/tazobactam (as above + Gram negative, including Pseudomonas species
37
Q

Cephalosporins

A

Broad-spectrum but no anaerobe activity – don’t act on anaerobic bacteria (e.g. clostridium)

  • Cetriaxone has good activity in the CSF
  • Concern over association with C. difficile major side effect of this drug is c.difficile infection
  • Ceftazidime + avibactam and ceftolozane + tazobactam used for multidrug resistant Gram negative infections
38
Q

Carbapenems

A

→ safe if allergic to penicillin

	•  Imipenem
	•  meropenem 
	• ertapenem 
	– very broad spectrum (incl anaerobes) 
	– active against most (not all) Gram negatives 
	– generally safe in penicillin allergy

• imipenem + relebactam
– serious Gram negative infections (including anaerobes)

• meropenem + vaborbactam – complicated Gram negative UTI

39
Q

3 types of glycopeptides

A

—> interfere with cell wall synthesis

Vancomycin
Teicoplanin
Dalbavancin and telavancin

40
Q

Vancomycin

A

– active against most Gram positive (not Gram negative)
– some enterococci resistant (VRE)
– resistance in staphs rare
– not absorbed (oral for C. difficile only as it acts locally), normally given intravenously for other infections
– therapeutic drug monitoring (TDM) required (narrow therapeutic window)

41
Q

Tetracyclines

Impact bacteria protein synthesis

A

Tetracycline & doxycycline
– similar spectrum, both oral only
– broad-spectrum but specific use in penicillin allergy, usually for Gram positive
– active in atypical pathogens in pneumonia
– active against chlamydia & some protozoa
– should not be given to children <12 years = as it affects mineralising tissue

42
Q

Aminoglycosides

  • impact bacteria protein synthesis
A

Most common agent is gentamicin = can be quite toxic

  • Profound activity against Gram negative
  • Good activity in the blood/urine
  • Potentially nephrotoxic/ototoxic
  • Therapeutic drug monitoring (TDM) required
  • Generally reserved for severe Gram negative sepsis
43
Q

Macrolides

  • impact bacteria protein synthesis
A

e.g. erythromycin (& clarithromycin)
• Well distributed including intracellular penetration
• Alternative to penicillin for mild Gram positive infections
• Also active against atypical respiratory pathogens

44
Q

Antifungals

A

• Azoles (active against yeasts +/- molds
– inhibit cell-membrane synthesis
– fluconazole used to treat Candida
• Itra/vori/posaconazole also active against Aspergillus

• Polyenes (nystatin and amphotericin) – inhibit cell membrane function
– nystatin for topical treatment of Candida
– amphotericin for IV treatment of systemic fungal infections (e.g. Aspergillus)

Fungal infections = very severe in immunocompromised patients

45
Q

Metronidazole – antibacterial and antiprotozoal agents

A

• Active against anaerobic bacteria

• Also active against protozoa:
– Amoebae (dysentery & systemic)
– Giardia (diarrhoea)
– Trichomonas (vaginitis)

46
Q

Antivirals

A

• Aciclovir
– when phosphorylated inhibits viral DNA polymerase = inhibit DNA viruses
– Herpes simplex – genital herpes, encephalitis
– Varicella zoster – chicken pox & shingles

• Oseltamivir (‘Tamiflu’)
– inhibits viral neuraminidase = stops virus from leaving the cell
– influenza A & B

• Specialist agents for HIV, HBV, HCV, CMV

47
Q

Process of antibiotic resistance

A

→ through natural selection

1. Genetic mechanisms confer drug resistance due to mutations and genetic variation
2. Antibiotics kill non-resistant bacteria
3. Drug resistant bacteria selected and reproduce due to competitive advantage (less competition for food and space etc)
4. Drug resistance gene transmitted through (exposure naïve) population
48
Q

3 levels of antibiotic resistance

A

MDR (multi-drug resistant)
XDR (extensively drug resistant)
PDR (pan-drug resistant)

49
Q

MDR (multi-drug resistant)

A

Non-susceptibility to at least one agent in three or more antimicrobial categories

50
Q

XDR (extensively drug resistant)

A

• Non-susceptibility to at least one agent in all but two or fewer antimicrobial categories

51
Q

PDR (pan-drug resistant)

A
  • Non-susceptibility to all agents in all antimicrobial categories
    • Smallest populations of bacteria
52
Q

Relationship between antimicrobial use and resistance

A

As prescribing and use increases so does resistance

53
Q

3 forms of Evidence that anti-bacterials cause resistance

A

Laboratory evidence
Ecological studies
Individual level data

54
Q

Laboratory evidence

A
  • Provides biological plausibility

* Colonies growing on agar plates – see antibiotics working

55
Q

Ecological studies

A
  • Relates levels of antibacterial use in a population with levels of resistance
    • Patterns of resistance and prescribing
56
Q

Individual level data

A

• Relates prior antibacterial use in an individual with the subsequent presence of bacterial resistance (detected by culture or molecular means)

57
Q

Pharmaceutical companies and antiniotics

A
  • Get a lot of money for making medications for chronic conditions
    • Not much money to be made in antibiotics
    • Hard to make antibiotics from scratch as we don’t have enough understanding
58
Q

Define antimicrobial stewardship

A

Commitment to always use antibiotics appropriately and safe
Only when they are needed
Choose right antibiotics and administer them in the right way

59
Q

Why do GP staff prescribe antibiotics – inappropriately

A

• Relief of symptoms
○ They think the antibiotics might work, better than just leaving the infection

• Worry about complications/more serious illness 
	○ Worried that leaving it untreated may lead to something more serious

• Patient pressure 
	○ what the patient wants, we want to be liked by patients
60
Q

IDSA defintion of antimicrobial

Stewardship

A

Coordinated interventions designed to improve and measure the appropriate use of antimicrobials by promoting the selection of the optimal antimicrobial drug regimen, dose, duration of therapy, and route of administration. Antimicrobial stewards seek to achieve optimal clinical outcomes related to antimicrobial use, minimize toxicity and other adverse events, reduce the costs of health care for infections, and limit the selection for antimicrobial resistant strains

61
Q

Symptom benefit from antibiotics

A

—> if antibiotics are given appropriately, duration of infection can be reduced

• The antibitoics do relieve symptoms but patients need to understand if the antibiotics will actually be benefical for them

NNT – number needed to treat
• NNT for an adverse effect is always lower than the NNT for one additional benefit to patient
• If you take na antibiotic and give it to patient= you are more likely to harm them than improve them if the antibiotic is given inappropriately

62
Q

3 Elements of antimicrobial stewardship programme

A

• MDT

Surveillance

Interventions

63
Q

• MDT

A

Effective collaboration across multidisciplinary team in implementing antimicrobial stewardship

64
Q

• Surveillance

A

– Process measures
• Antibacterial use (quantity, type, appropriateness)
• Benchmarking within and between organisations

– Outcome measures 
• Patient 
• Emergence of resistant organisms
65
Q

• Interventions

A

– Persuasive = people, opinions, advice
– Restrictive = rules and regulations
– Structural = • Computerised records, Rapid lab tests, Expert systems,Quality monitoring

66
Q

Cellulitis - cause

A

Infection of deep dermis

Streptococcus pyogenes

Staphylococcus aureus

67
Q

How does phagocytotic cell recognise pathogen

A

Prp recognise pamps

68
Q

Cellutis supportive treatment

A

Nsaid

Pain relief

Elevation and immobilisation of leg

Saline dressings

69
Q

Antibiotics for cellulitis

A

Vancomyosin
flucloxacilin
Doxycilin

70
Q

Dysuria

A

Difficulty, pain , discomfort passing urine

Y1 TP2 Infection (topic 3 Onwards) (9 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions